Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial-Reference-Cited by-同舟云学术

Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial

Published:2017-11-29 Issue:3 Volume:73 Page:757-763
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Kontoyiannis Dimitrios P¹,Selleslag Dominik²,Mullane Kathleen³,Cornely Oliver A⁴,Hope William⁵,Lortholary Olivier⁶,Croos-Dabrera Rodney⁷,Lademacher Christopher⁷,Engelhardt Marc⁸,Patterson Thomas F⁹

Affiliation:

1. Department of Infectious Diseases, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

2. AZ Sint Jan Brugge Oostende AV, Brugge, Belgium

3. Department of Medicine/Section of Infectious Diseases, University of Chicago, Chicago, IL, USA

4. Department I for Internal Medicine, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, Clinical Trials Centre, University of Cologne (ZKS Köln), Cologne, Germany

5. University of Liverpool, Liverpool, UK

6. Université Paris Descartes, Centre d’Infectiologie Necker Pasteur, Paris, France

7. Astellas Pharma Global Development, Inc., Northbrook, IL, USA

8. Basilea Pharmaceutica International Ltd, Basel, Switzerland

9. Infectious Disease, UT Health San Antonio and the South Texas Veterans Health Care System, San Antonio, TX, USA

Funder

Astellas Pharma US

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link